MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma
- PMID: 31018244
- DOI: 10.1002/ijc.32368
MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma
Abstract
Osteosarcoma (OS) is an aggressive malignancy affecting mostly children and adolescents. MicroRNAs (miRNAs) play important roles in OS development and progression. Here we found that miR-16-1-3p and miR-16-2-3p "passenger" strands, as well as the "lead" miR-16-5p strand, are frequently downregulated and possess strong tumor suppressive functions in human OS. Furthermore, we report different although strongly overlapping functions for miR-16-1-3p and miR-16-2-3p in OS cells. Ectopic expression of these miRNAs affected primary tumor growth, metastasis seeding and chemoresistance and invasiveness of human OS cells. Loss-of-function experiments verified tumor suppressive functions of these miRNAs at endogenous levels of expression. Using RNA immunoprecipitation (RIP) assays, we identify direct targets of miR-16-1-3p and miR-16-2-3p in OS cells. Moreover, validation experiments identified FGFR2 as a direct target for miR-16-1-3p and miR-16-2-3p. Overall, our findings underscore the importance of passenger strand miRNAs, at least some, in osteosarcomagenesis.
Keywords: FGFR2; RIP; metastasis; miR-16-1; miR-16-2; miR-16-5p; osteosarcoma; tumor suppressor.
© 2019 UICC.
Similar articles
-
Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.Mol Cancer. 2019 Apr 2;18(1):73. doi: 10.1186/s12943-019-1007-1. Mol Cancer. 2019. PMID: 30940151 Free PMC article.
-
Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.Mol Carcinog. 2017 Apr;56(4):1312-1321. doi: 10.1002/mc.22593. Epub 2016 Nov 29. Mol Carcinog. 2017. PMID: 27859625
-
MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.Clin Exp Metastasis. 2016 Apr;33(4):359-72. doi: 10.1007/s10585-016-9783-0. Epub 2016 Feb 25. Clin Exp Metastasis. 2016. PMID: 26913720 Free PMC article.
-
Advances in targeted therapy for osteosarcoma.Discov Med. 2014 Jun;17(96):301-7. Discov Med. 2014. PMID: 24979249 Review.
-
Molecular Biology of Osteosarcoma.Cancers (Basel). 2020 Jul 31;12(8):2130. doi: 10.3390/cancers12082130. Cancers (Basel). 2020. PMID: 32751922 Free PMC article. Review.
Cited by
-
MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.Front Oncol. 2023 Aug 31;13:1220459. doi: 10.3389/fonc.2023.1220459. eCollection 2023. Front Oncol. 2023. PMID: 37719019 Free PMC article.
-
Expansion of plasma MicroRNAs over the first month following human stroke.J Cereb Blood Flow Metab. 2023 Dec;43(12):2130-2143. doi: 10.1177/0271678X231196982. Epub 2023 Sep 11. J Cereb Blood Flow Metab. 2023. PMID: 37694957 Free PMC article.
-
PVT1/miR-16/CCND1 axis regulates gastric cancer progression.Open Med (Wars). 2023 Jan 31;18(1):20220550. doi: 10.1515/med-2022-0550. eCollection 2023. Open Med (Wars). 2023. PMID: 36760720 Free PMC article.
-
Long non-coding RNA MALAT1 promotes cell proliferation, migration and invasion by targeting miR-590-3p in osteosarcoma.Exp Ther Med. 2022 Sep 14;24(5):672. doi: 10.3892/etm.2022.11608. eCollection 2022 Nov. Exp Ther Med. 2022. PMID: 36277152 Free PMC article.
-
Small Nucleolar Derived RNAs as Regulators of Human Cancer.Biomedicines. 2022 Jul 28;10(8):1819. doi: 10.3390/biomedicines10081819. Biomedicines. 2022. PMID: 36009366 Free PMC article. Review.
References
-
- Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009;152:3-13.
-
- Szuhai K, Cleton-Jansen AM, Hogendoorn PC, et al. Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 2012;205:193-204.
-
- Maximov VV, Aqeilan RI. Genetic factors conferring metastasis in osteosarcoma. Future Oncol 2016;12:1623-44.
-
- Smith MA, Altekruse SF, Adamson PC, et al. Declining childhood and adolescent cancer mortality. Cancer 2014;120:2497-506.
-
- Jaffe N. Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication. Cancer Treat Res 2009;152:219-37.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
